About Avi Naider
Avi Naider is a board member at Iliad Biotechnologies.
Form D filings also name Avi Naider as a director at Treeline Biosciences.
Avi Naider first appears on SEC filings in 2021.
Experience
This experience comes from Avi Naider's profile and from SEC filings. For roles taken from filings, the years are when the filings name Avi Naider in the role, so the role may have started earlier or lasted longer.
TG
Tri-state Medical Group Current
Chairman of the Board
2023 – Present
Iliad Biotechnologies, Inc. Current
Board Member
2021 – Present · Weston, FL
Develops an investigational whooping cough vaccine for people at risk of infection.
PR
Protosthetics Current
Chairman of the Board
2021 – Present
DA
Denti.AI Current
Chairperson of the Board
2020 – Present
AL
AI Life Sciences LLC Current
President
2016 – Present
AM
ACES Quality Management Current
Board Member
2008 – Present
VW
Vero Water
Board of Directors
2010 – 2021
LL
Loxo@Lilly
Board of Directors
2013 – 2019
MC
MeMedia (formerly WhenU.com)
Founder, CEO, President
2000 – 2006
AL
AEA Investors LP
Associate
1997 – 1999
TG
The Boston Consulting Group
Associate
1994 – 1996
Key Colleagues at Startups
The people Avi Naider works with at each company, as listed on that company's latest Form D.
Iliad Biotechnologies, Inc. · Form D, Feb 20, 2026
WS
William Steinkrauss
Executive officer
Mario Barro
Board Member
Eric Edidin
Board Member
Keith Rubin
Board Member
Treeline Biosciences, Inc. · Form D, Sep 4, 2025
SE
Steven Elms
Director
KB
Kristina Burow
Director
DB
David Bonita
Director
JB
Joshua Bilenker
Executive officer, director and promoter
JE
Jeffrey Engelman
Executive officer, director and promoter
AK
Aftab Kherani
Director
AS
Ali Satvat
Director
DS
David Schenkein
Director